Manu Hegde, Ph.D.
Affiliations: | 2006 | University of California, Davis, Davis, CA |
Area:
Neuroscience BiologyGoogle:
"Manu Hegde"Parents
Sign in to add mentorFredric A. Gorin | grad student | 2006 | UC Davis | |
(Amiloride-associated death in human glioma cells.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Young AC, Yiannoutsos CT, Hegde M, et al. (2014) Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology. 83: 1592-600 |
Hegde M, Lowenstein DH. (2014) The search for circulating epilepsy biomarkers. Biomarkers in Medicine. 8: 413-27 |
Vossel KA, Beagle AJ, Rabinovici GD, et al. (2013) Seizures and epileptiform activity in the early stages of Alzheimer disease. Jama Neurology. 70: 1158-66 |
Kamel H, Betjemann JP, Navi BB, et al. (2013) Diagnostic yield of electroencephalography in the medical and surgical intensive care unit. Neurocritical Care. 19: 336-41 |
Kamel H, Johnson DR, Hegde M, et al. (2012) Detection of atrial fibrillation after stroke and the risk of recurrent stroke. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 21: 726-31 |
Harley W, Floyd C, Dunn T, et al. (2010) Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas. Brain Research. 1363: 159-69 |
Kamel H, Hegde M, Johnson DR, et al. (2010) Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke; a Journal of Cerebral Circulation. 41: 1514-20 |
Kamel H, Cornes SB, Hegde M, et al. (2010) Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocritical Care. 12: 204-10 |
Palandoken H, By K, Hegde M, et al. (2005) Amiloride peptide conjugates: prodrugs for sodium-proton exchange inhibition. The Journal of Pharmacology and Experimental Therapeutics. 312: 961-7 |